Abbott Completes Separation of Research-Based Pharmaceuticals Business
date:Jan 04, 2013
The company is comprised of four businesses of roughly equal size diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. Abbott's businesses are all leaders in their respective fields and hold the top market positions across numerous categories. These businesses develop leading, science-based products that are meeting the needs of patients and consumers in the evolving global healthcare environment.

Abbott is well positioned to deliver reliable performance with industr
5/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/06 03:25